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The effect of zinc deficiency in aged C57BL/6J mice  
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CN 185 (31%) 35 (32%) 60 (37%) 161 (31%) 17 (40%) 20 (31%) 131 (20%)
EMCI 116 (20%) 29 (26%) 32 (20%) 70 (13%) 3 (7%) 15 (23%) 129 (20%)
LMCI 199 (33%) 37 (33%) 54 (33%) 199 (31%) 18 (42%) 26 (40%) 219 (33%)
AD 89 (15%) 10 (9%) 16 (10%) 94 (18%) 5 (12%) 4 (6%) 176(26%)
ADAS 15.8 (9.1)*** 14.8 (8.3) ns 14.1 (9.0)** 17.0 (9.3)ns 14.7 (7.0) ns 14.2 (6.9)ns 18.9 (10.1)
2 (6)=48.7
p<0.0001






Male 385 (65%) 56 (50%) 91 (56%) 200 (38%) 14 (33%) 25 (38%) 232 (35%)
Female 204 (35%) 55 (50%) 71 (44%) 324 (62%) 29 (67%) 29 (67%) 423 (65%)





-/- 321 (54%) 68 (61%) 86 (53%) 292 (56%) 23 (55%) 37 (57%) 315 (48%)
+/- 209 (35%) 32 (29%) 62 (38%) 185 (35%) 16 (36%) 25 (38%) 261 (40%)




Primary 200 (34%) 37 (33%) 57 (35%) 193 (37%) 26 (60%) 22 (34%) 223 (34%)
Secondary 155 (26%) 26 (23%) 48 (30%) 151 (29%) 10 (23%) 24 (37%) 197 (37%)
Te 136 (23%) 30 (27%) 30 (19%) 102 (20%) 4 (9%) 10 (15%) 115 (15%)
Post-graduate 98 (17%) 18 (16%) 27 (17%) 78 (17%) 3 (7%) 9 (14%) 120 (14%)
Headache 65 (11%) 10 (9%) 14 (8%) 48 (9%) 5  (11%) 4 (6%) 42 (6%) 2 (6)=9.5
p=0.1495
Arthr 261 (44%) 57 (51%) 70 (43%) 226 (43%) 19 (44%) 31 (48%) 213 (33%) 2 (6)=29.8
P<0.0001
Diabetes 37 (4%) 14 (8%) 9 (4%) 47 (6%) 2 (3%) 7 (7%) 42 (4%) 2 (6)=10.7
p=0.0980
Smoker 140 (24%) 30 (27%) 44 (27%) 129 (24%) 11 (24%) 11 (16%) 176 (27%) 2 (6)=4.6
p=0.600
Cardiovascular 
risk factors 346 (59%) 70 (63%) 91 (56%) 322 (61%) 25 (58%) 40 (61%) 413 (63%)
2(6)=4.4
p=0.6267
Total 509 111 162 524 43 65 655
*** ***** **nsns
Calcium Iron Magnesiu Multi-vitamin Selenium Zinc
185 (31%) 35 2 60 (37 ) 161 (31%) 17 40 20 (31 )
116 (20%) 29 6 32 20 70 13%) 3 7%) 15 (23 )
199 (33%) 37 54 (33 ) 199 (31%) 18 2 26 (40 )
89 (15%) 10 (9 ) 16 0 94 (18%) 5 (12%) 4 (6%)
15.8 (9.1)*** .8 (8.3) ns 4.1 ( .0)** 7.0 9.3 7 7 0 s 4 2 6.9)ns
27.3 (2.6)*** 7.2 ( .6) ns 8 0 4  * .7 ( .2) 6 4  ns 27.4 (2.5)ns
385 (65%) 56 0 91 (56 ) 200 (38%) 14 3 25 (38 )
204 (35%) 55 50 71 (44 ) 324 (62%) 40 (62 )
3.8 ( .0)** 4 3 7 1 ns 2 9 6 7 .4 (7.1)* 4 5 6 2 73.4 (7.1) ns
321 (54%) 68 61 86 (53 ) 292 (56%) 23 5 37 (57 )
209 (35%) 3 29 62 (38 ) 185 (35%) 16 6 25 (38 )
59 11 (10%) 14 47 (9%) 4 9 3 5%)
200 (34%) 3 3 57 (35 ) 193 (37%) 6 60 22 (34 )
155 (26%) 26 23 48 (30 ) 151 (29%) 10 23 24 (37 )
136 (23%) 27 30 (19 ) 102 (20%) 4 9%) 10 (15 )
9 7 18 6 27 78 17%) 3 (7 ) 9 (14%)
65 (11%) 0 9 14 8 48 (9 5  (11%) 4 (6 )
261 (44%) 57 51 70 (43 ) 226 (43%) 19 4 31 (48 )
37 4 14 (8%) 9 (4 ) 47 (6%) 2 3 7 (7 )
140 (24%) 30 44 (27 ) 129 (24%) 24 11 (16 )
346 (59%) 70 63 91 (56 ) 322 (61%) 25 58 40 (61 )



























































































Main E ect Interac on E ect (with me)
Es mate StandardError
 p-value Stainclusion Es mate  p-value









CN - - - - - -
EMCI 0.708 0.066 p <0.00001 -0.00332 0.0010 p =0.00145
LMCI 1.242 0.056 p <0.00001 0.00286 0.0007 p =0.00008
AD 2.11 0.062 p <0.00001 0.00880 0.0014 p <0.00001
Age 0.018 0.003 p <0.00001
2(1)=48.2,






Female - - - - - -






-/- - - - - - -
+/- 0.121 0.042 p =0.00446 0.00588 0.0006 p <0.00001






Primary 0.352 0.057 p <0.00001 -0.00250 0.0008 p =0.00224
Secondary 0.362 0.056 p <0.00001 -0.00226 0.0008 p =0.00532
Ter ary 0.2 0.050 p =0.00005 -0.00375 0.0007 p <0.00001
Post-graduate - - - - - -
Calcium 0.09880 0.04305 p =0.02172
2 (1)=3.0, 
p=0.08326 0.00117 0.0006 p =0.05361
2 (1)=3.8, 
p=0.05125
Iron 0.12126 0.0758 p =0.11007
2 (1)=0.8, 
p=0.37110 0.00192 0.0008 p =0.02023
2 (1)=5.4, 
p=0.02014
Magnesium 0.11233 0.06666 p =0.09198
2 (1)=4.4, 
p=0.03594 0.00059 0.0009 p =0.49260
2 (1)=0.4, 
p=0.5271
Mul -vitamin 0.00351 0.04150 p =0.93250
2 (1)=0, 
p=0.99999 0.00024 0.0006 p =0.68480
2 (1)=0.2, 
p=0.65470
Selenium 0.10269 0.12239 p =0.40145
2 (1)=2.2, 
p=0.13800 0.00218 0.0014 p =0.11098
2 (1)=2.6, 
p=0.10690
Zinc 0.07117 0.09972 p =0.04755
2 (1)=2.2, 
p=0.13800 0.00207 0.0007 p =0.00511
2 (1)=7.4, 
p=0.00540
All Supplements 0.03760 0.04024 p =0.35018
2 (1)=1.2, 
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TPEN (μM) 0 1 3 10 30
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ZnCl  (μM) 0 10 30 100 300 1000
Silica (300μg/ml) + + + + + +
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